Raymond James & Associates’s Kite Pharma, Inc. KITE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-13,012
| Closed | -$2.34M | – | 3438 |
|
|
2017
Q3 | $2.34M | Buy |
13,012
+478
| +4% | +$86K | ﹤0.01% | 1543 |
|
|
2017
Q2 | $1.3M | Sell |
12,534
-5,332
| -30% | -$553K | ﹤0.01% | 1854 |
|
|
2017
Q1 | $1.4M | Buy |
17,866
+5,587
| +46% | +$438K | ﹤0.01% | 1769 |
|
|
2016
Q4 | $551K | Buy |
12,279
+5,973
| +95% | +$268K | ﹤0.01% | 2272 |
|
|
2016
Q3 | $352K | Buy |
+6,306
| New | +$352K | ﹤0.01% | 2503 |
|
|
2016
Q2 | – | Sell |
-6,469
| Closed | -$297K | – | 2996 |
|
|
2016
Q1 | $297K | Buy |
+6,469
| New | +$297K | ﹤0.01% | 2336 |
|